Pharma & Biotech News #PharmaBuzz

FAMAR CDMO- From early development to commercial manufacturing.

Weekly News Recap #Phispers

FDA chief Marty Makary resigns after rocky tenure; Italy's Angelini to buy Catalyst Pharma for US$ 4.1 billion

The US Food and Drug Administration (FDA) has seen several high profile exits under the Trump Administration. The most high pro...

Impressions : 1294

FDA issues warning letter to Intas' plant in north India; okays Axsome's drug for Alzheimer's-related agitation

In Phispers this week, India’s Intas Pharmaceuticals received a warning letter from the US Food and Drug Administration (...

Impressions : 1840

India's Sun Pharma acquires Organon for about US$ 11.75 bn; Lilly to buy Ajax Therapeutics for up to US$ 2.3 bn

In Phispers this week, Indian drugmaker Sun Pharmaceutical acquired Jersey-based Organon in an all-cash deal valued at about US...

Impressions : 1730

Lilly buys biotech Kelonia for up to US$ 7 bn; Trump orders priority review of psychedelic drugs to treat mental illnesses

Eli Lilly has been on an acquisition spree this year. After buying Ventyx Biosciences, Orna Therapeutics, CrossBridge Bio, and...

Impressions : 1469

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

FDA chief Marty Makary resigns after rocky tenure; Italy's Angelini to buy Catalyst Pharma for US$ 4.1 billion

FDA issues warning letter to Intas' plant in north India; okays Axsome's drug for Alzheimer's-related agitation

India's Sun Pharma acquires Organon for about US$ 11.75 bn; Lilly to buy Ajax Therapeutics for up to US$ 2.3 bn

Lilly buys biotech Kelonia for up to US$ 7 bn; Trump orders priority review of psychedelic drugs to treat mental illnesses

Mylan's Generics Levetiracetam Receives Approval in US

Dr. Reddy's Generics Empagliflozin Receives Tentative Nod in US

Lachman's Dolutegravir, Lamivudin Receives Tentative Nod in US

Micro's Generics Brimonidine Tartrate Receives Approval in US

Zydus' Generics Hydrocortisone Sodium Receives Approval in US

Accord Biopharma's Biologics Ennumo Receives Approval in US

I3 Pharms' Generics Paliperidone Receives Approval in US

Sandoz's Generics Vasopressin Receives Approval in US

Zhejiang Novous's Generics Voriconazole Receives Approval in US

Yichang Humanwell's Generics Bupropion Receives Approval in US

Pharmacal Issues Nationwide Recall of MG217 Eczema Cream

Mukesh B Chandre's Receives FDA Warning Letter

IDO Pharma's Receives FDA Warning Letter

ProRx's Receives FDA Warning Letter

Enforcement Report - Week of May 6, 2026

CareFusion 213's Receives FDA Warning Letter

Ava's Receives FDA Warning Letter

Active Cosmetics Manufacturing's Receives FDA Warning Letter

Respilon Production S R O's Receives FDA Warning Letter

Intas' Receives FDA Warning Letter

Mankind Launches 'Act At 30' for Heart Health Screening

Akums Q4 Revenue Climbs To Rs. 1,158 Crore; PAT Surges 135%

Lupin Launches Atharv Ability Neuro-Rehab Center in Delhi

ImmunityBio Signs U.S. BCG Supply Deal With Japan Lab

Alembic Pharma Q4 Revenue Rises To Rs. 1,848 Crore

Wuxi Apptec Tops 2026 Dow Jones World Index

Caplin Steriles Gets USFDA Nod for Generic Foscarnet Sodium

Nanobiotix Presents JNJ-1900 Data in Inoperable Lung Cancer

Design Therapeutics To Host Investor Webcast On DT-216P2

Harbour BioMed Announces LET003 as First AI-Enabled Drug

Caplin Steriles Gets USFDA Nod for Generic Foscarnet Sodium

FDA Approves Tecentriq for ctDNA-Guided Adjuvant Bladder Cancer

Alembic Pharma Gets USFDA Tentative Approval for Darolutamide

Semaglutide Price Drop Expected Amid Generic Expansion In India

Towa International Promotes Debate on Generic Medicines

Generic Entry Sparks GLP-1 Boom in India

Lupin Receives U.S. FDA Approval For Famotidine Injection, USP

FDA Accepts Transpire Bio's ANDA for Generic Trelegy® Ellipta®

Avenacy Launches Tranexamic Acid in 0.7% NaCl for U.S. Market

Biocon Arm Wins Health Canada Nod for Antifungal Drug

Nanobiotix Presents JNJ-1900 Data in Inoperable Lung Cancer

Design Therapeutics To Host Investor Webcast On DT-216P2

Harbour BioMed Announces LET003 as First AI-Enabled Drug

LOTTE Biologics Expands Antibody Deal With Ottimo

Ipsen Unveils Phase II Corabotase Data: Prolonged Efficacy

Regeneron's LAG-3 Combo Fails Late-Stage Melanoma Trial

Psmaddition Data Reveals 58% Lower PSA Progression Risk

Strategic Design Tackles Drug-Resistant Cancer Targets

Case Series Reviews ADSTILADRIN for NMIBC Patients

Nabsys Expand OhmX Installs via Hitachi RAMP UP for Blood Cancers

Imports Of Bulk Drugs Decline 3.31 Per Cent In FY26

Patent Pause: Link Extensions to Pendency

EUROAPI statement regarding the Brindisi site

Medisca & dsm–firmenich Expand Pharma-Grade Vitamin APIs in U.S.

Drugmakers Seek NPPA Aid as Platinum Surge Hits Cancer Drug

BMS Wins EU Approval for Sotyktu in Active Psoriatic Arthritis

Carbogen Amcis Shanghai Site Passes Surprise NMPA GMP Inspection

India's Emerging Pharma Powerhouses

Lilly Pledges $4.5 Billion More To Indiana Manufacturing Campus

DC Granules: Sitagliptin, Empagliflozin, Dapagliflozin, Metformin

Sun Pharma Recalls Cancer Drug Due To Glass Particles

KSRPA Alerts Karnataka Govt On Drugs And Cosmetic Act

FDA Official Details Top Observations From QMSR Inspections

Indoco Remedies Clears Malta Medicines Authority Audit

FDA Drafts Guidelines On High-Risk Solvents Post Tainted Syrup

Eli Lilly Halts India Obesity Campaign Amid Regulatory Scrutiny

Exporters Face WHO GMP CoPP Delays on ONDLS Online Platform

FDA Rejections Cite Manufacturing and Data Gaps as Key Hurdles

Kennedy Officials Mulled U.S. Ban on Common Antidepressants

Drug Regulator Cracks Down on Late Safety Reports by Pharma

Mankind Launches 'Act At 30' for Heart Health Screening

Experts Calls for Preventive Action as Hypertension Cases Rise

WHO Declares Congo-Uganda Ebola Outbreak a Global Emergency